Medicare Enrolled

Dr. Ifeoma Egbuonu, MD

Endocrinology · El Paso, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
2270 JOE BATTLE BLVD STE O, El Paso, TX 79938
9158567000
Registered in NPPES since 2014
NPI: 1083010060 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Egbuonu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Egbuonu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Egbuonu

Dr. Ifeoma Egbuonu is an endocrinology specialist in El Paso, TX, with 11 years of NPI registration. Based on federal Medicare data, Dr. Egbuonu performed 1,554 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Egbuonu received a total of $10,596 from 45 pharmaceutical and/or device companies across 592 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Egbuonu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years of NPI registration ▲ Top 27% volume in TX $10,596 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,554
Medicare services
Top 27% in TX for endocrinology
Not available
Unique patients (not deduplicated)
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
513 $87 $190
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
397 $3 $25
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
245 $58 $134
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
152 $24 $52
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
75 $116 $246
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
59 $70 $164
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
35 $69 $191
Ultrasound-guided fine needle aspiration biopsy, first lesion
A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session.
29 $103 $200
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
27 $10 $50
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
22 $48 $134
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,596
Total received (2018-2024)
Avg $1,514/year across 7 years
Top 31% in TX for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
592
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,246
2023
$2,160
2022
$2,486
2021
$1,579
2020
$785
2019
$918
2018
$422

Payments by company (2024)

Abbott Laboratories
$360
Lilly USA, LLC
$336
Bayer Healthcare Pharmaceuticals Inc.
$265
Corcept Therapeutics
$229
Boehringer Ingelheim Pharmaceuticals, Inc.
$184
ABBVIE INC.
$170
Novo Nordisk Inc
$112
Insulet Corporation
$102
Dexcom, Inc.
$81
Tandem Diabetes Care, Inc.
$77
Amgen Inc.
$68
Radius Health, Inc.
$35
Xeris Pharmaceuticals, Inc.
$34
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$31
SANOFI-AVENTIS U.S. LLC
$29
BETA BIONICS, INC.
$29
PFIZER INC.
$20
Novartis Pharmaceuticals Corporation
$19
Esperion Therapeutics, Inc.
$18
Regeneron Healthcare Solutions, Inc.
$18
Alexion Pharmaceuticals, Inc.
$17
Ascensia Diabetes Care Us Inc.
$14
Top 3 companies account for 42.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,643
Medtronic, Inc.
$1,088
AstraZeneca Pharmaceuticals LP
$920
Boehringer Ingelheim Pharmaceuticals, Inc.
$885
Abbott Laboratories
$826
Lilly USA, LLC
$658
Insulet Corporation
$579
Bayer Healthcare Pharmaceuticals Inc.
$545
Corcept Therapeutics
$499
SANOFI-AVENTIS U.S. LLC
$378
AbbVie Inc.
$324
Echosens North America, Inc.
$275
ABBVIE INC.
$186
Merck Sharp & Dohme Corporation
$186
Xeris Pharmaceuticals, Inc.
$175
Dexcom, Inc.
$172
Amgen Inc.
$168
Novartis Pharmaceuticals Corporation
$132
Tandem Diabetes Care, Inc.
$132
Inspire Medical Systems, Inc.
$109
Regeneron Pharmaceuticals, Inc.
$73
Radius Health, Inc.
$62
Alexion Pharmaceuticals, Inc.
$61
MannKind Corporation
$59
Amarin Pharma Inc.
$51
DEXCOM, INC.
$39
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$31
Regeneron Healthcare Solutions, Inc.
$30
BETA BIONICS, INC.
$29
Janssen Pharmaceuticals, Inc
$28
Bayer HealthCare Pharmaceuticals Inc.
$23
Ultragenyx Pharmaceutical Inc.
$22
Astellas Pharma US Inc
$21
PFIZER INC.
$20
Antares Pharma, Inc.
$19
Esperion Therapeutics, Inc.
$18
Avion Pharmaceuticals
$17
Merck Sharp & Dohme LLC
$17
Kyowa Kirin, Inc.
$14
Medtronic MiniMed, Inc.
$14
Ascensia Diabetes Care Us Inc.
$14
Shire North American Group Inc
$14
Horizon Therapeutics plc
$13
RECORDATI_RARE_DISEASES_INC.
$12
AbbVie, Inc.
$12
Top 3 companies account for 34.5% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BASAGLAR · Crysvita · DEXCOM CGM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVKEEZA · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FibroScan · FreeStyle Libre · FreeStyle Libre 2 · GLYXAMBI · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INSPIRE · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · MINIMED 770G · MOUNJARO · Minimed 770G System · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid 60 · Omnipod · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RECORLEV · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · SYNTHROID · Saxenda · Synthroid · TEPEZZA · TOUJEO · TRULICITY · TZIELD · Tresiba · Tymlos · UBRELVY · Vascepa · Veozah · Wegovy · XARELTO · XIFAXAN · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an endocrinology specialist in El Paso?
Compare endocrinologists in the El Paso area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists in nearby ZIP areas
6
County median income
$58,859
Nearest hospital to ZIP centroid (approximate)
THE HOSPITALS OF PROVIDENCE - EAST CAMPUS
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Egbuonu is a clinical cardiology specialist, with above-average Medicare volume (top 27% in TX).

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Egbuonu experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Egbuonu performed 513 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Egbuonu receive payments from pharmaceutical companies?
Yes. Dr. Egbuonu received a total of $10,596 from 45 companies across 592 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Egbuonu's costs compare to other endocrinologists in El Paso?
Dr. Egbuonu's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Egbuonu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →